Company Filing History:
Years Active: 1977
Title: The Innovative Contributions of William S. Simmons
Introduction
William S. Simmons is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of central nervous system (CNS) conditions. With a total of 3 patents to his name, Simmons has focused on developing methods and compounds that address serious health issues.
Latest Patents
Simmons' latest patents include groundbreaking methods for treating CNS lymphoma and meningeal leukemia. One of his notable inventions is a method and pharmaceutical preparation for treating CNS lymphoma and neoplasms in the brain. This involves administering an effective treatment amount of a compound of Formula I, where R is a straight or branched chain lower alkyl of 1 to 4 carbon atoms, and X is a halogen atom such as fluorine, chlorine, bromine, or iodine. Preferred compounds for these treatments include 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methyl-pyrimidine and 2,4-diamino-5-(3',4'-dichlorophenyl)-6-ethyl-pyrimidine.
Another significant patent focuses on the treatment of meningeal leukemia using diamino dichlorophenyl pyrimidine. This method also involves treating an infected mammal, such as a human, with a compound of Formula I, similar to his previous patent. The compounds mentioned are crucial for the effective treatment of the aforementioned diseases.
Career Highlights
William S. Simmons is associated with Burroughs Wellcome Co., a company known for its innovative pharmaceutical developments. His work has contributed to advancements in medical treatments, particularly in oncology and hematology.
Collaborations
Simmons has collaborated with notable coworkers such as Dwight R. Stickney and Charles A. Nichol. Their combined efforts have led to significant advancements in the pharmaceutical field.
Conclusion
William S. Simmons is a distinguished inventor whose work has had a profound impact on the treatment of CNS conditions. His innovative patents and collaborations continue to influence the pharmaceutical industry and improve patient outcomes.